Article Versions Notes

Riffet M, Eid Y, Faisant M, Fohlen A, Menahem B, Alves A, Dubois F, Levallet G, Bazille C. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers. 2021; 13(23):5957. https://doi.org/10.3390/cancers13235957

Riffet, Marc, Yassine Eid, Maxime Faisant, Audrey Fohlen, Benjamin Menahem, Arnaud Alves, Fatéméh Dubois, Guénaelle Levallet, and Céline Bazille. 2021. "Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers" Cancers 13, no. 23: 5957. https://doi.org/10.3390/cancers13235957

Riffet, M., Eid, Y., Faisant, M., Fohlen, A., Menahem, B., Alves, A., Dubois, F., Levallet, G., & Bazille, C. (2021). Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers, 13(23), 5957. https://doi.org/10.3390/cancers13235957